Aptamer Group PLC (AIM: APTA)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.408
-0.012 (-2.90%)
Jan 21, 2025, 3:26 PM GMT+1

Aptamer Group Company Description

Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that combines the features of Optimer and antibodies.

It serves bioprocessing and diagnostic institutes, as well as pharmaceutical scientists. The company has strategic partnership with Unilever for the development of Optimer for use in deodorant, Neuro-Bio to develop reagents for Alzheimer’s disease test, and other pharma partner and AztraZeneca for drug delivery vehicle for fibrotic liver.

The company was founded in 2008 and is headquartered in York, the United Kingdom.

Aptamer Group PLC
Country United Kingdom
Founded 2008
Industry Biotechnology
Sector Healthcare
Employees 34
CEO Arron Tolley

Contact Details

Address:
Windmill House
York, YO10 5BR
United Kingdom
Phone 44 19 0421 7404
Website aptamergroup.com

Stock Details

Ticker Symbol APTA
Exchange London Stock Exchange AIM
Fiscal Year July - June
Reporting Currency GBP
ISIN Number GB00BNRRP542
SIC Code 2836

Key Executives

Name Position
Arron Tolley Chief Executive Officer
Andrew Rapson Chief Financial Officer